Today

Agents

Chat

Arena

Discover

More

App

Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027 - NTRA News | Rallies

Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027

NTRA•2026-09-22

Japan regulatory approval and launch timing

Sept. 22 (Reuters) - Natera, Inc. NTRA.O:

Signatera™ receives regulatory approval in Japan as a companion diagnostic in muscle-invasive bladder cancer
Natera says Signatera commercial launch in Japan is expected in 1H 2027

Related News

Amgen says Phase 3 OASIZ 301 trial meets primary endpoint for dazodalibep in systemic Sjögren's disease

AMGN•2026-09-22

Textron Systems’ Aerosonde UAS completes first commercial-airspace vertiport-to-vertiport flight in Virginia

TXT•2026-09-22

BlackBerry gains after first vehicle OS design win

BB•2026-09-22

JX Luxventure raises 2026 equity incentive plan share reserve to 9,300,000 from 4,500,000

JXG•2026-09-22

RedCloud issues 74,000 shares to CEO Justin Floyd at USD 2.5 in private placement

RCT•2026-09-22